CDER Compliance Office Redesign Includes Internet, Risk Management Focus
This article was originally published in The Tan Sheet
Executive Summary
The FDA Center for Drug Evaluation & Research's reorganized Office of Compliance includes a team focused on illegal sale of OTC and prescription drugs on the Internet